Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Their primary indication is the management of type 2 diabetes, where they are used alongside diet and exercise to improve glycaemic control by enhancing insulin secretion, suppressing glucagon, and supporting healthier glucose regulation 3 , 4
Novo Nordisk A/S, Veru Inc., Viking Therapeutics, Inc., Terns Pharmaceuticals, Inc., Eccogene, AstraZeneca, and others Some of the key GLP-1 agonists include
Then, in the small intestine, digestive enzymes such as peptidases strike
Full effects typically kick in after 68 months of consistent use, and if you havent lost at least 5% of your body weight by the 12-week mark, your doctor will likely reassess whether its the right fit for you
